These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36339467)

  • 1. Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation.
    Xin Q; Zhang C; Wang YJ; Li J; Chen T; Li SX; Wang W; Yang Y; Song WJ; Zhou J; Shi XM
    J Geriatr Cardiol; 2022 Aug; 19(8):565-574. PubMed ID: 36339467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
    Yang L; Gao LJ; Yin XM; Guo BL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430
    [No Abstract]   [Full Text] [Related]  

  • 3. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.
    Zhang RF; Ma CM; Wang N; Yang MH; Li WW; Yin XM; Dong YX; Yu XH; Xiao XJ; Xia YL; Gao LJ
    BMC Cardiovasc Disord; 2021 Apr; 21(1):214. PubMed ID: 33906609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Kinetics of Activated Clotting Time Among Uninterrupted Oral Anticoagulants During Catheter Ablation Procedure.
    Kawaji T; Morimoto T; Aizawa T; Hojo S; Kushiyama A; Yaku H; Nakatsuma K; Kaneda K; Kato M; Yokomatsu T; Miki S; Kimura T
    J Clin Pharmacol; 2022 Jun; 62(6):792-800. PubMed ID: 34921561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
    Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.
    Stepanyan G; Badhwar N; Lee RJ; Marcus GM; Lee BK; Tseng ZH; Vedantham V; Olgin J; Scheinman M; Gerstenfeld EP
    J Interv Card Electrophysiol; 2014 Jun; 40(1):33-8. PubMed ID: 24643666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation.
    Osawa T; Mori H; Kawai A; Kawano D; Tsutsui K; Ikeda Y; Yamaga M; Sato A; Gatate Y; Hamabe A; Tabata H; Kato R; Matsumoto K
    J Arrhythm; 2022 Feb; 38(1):58-66. PubMed ID: 35222751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Komtasubara I; Kusachi S
    Clin Drug Investig; 2016 Oct; 36(10):837-48. PubMed ID: 27389243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy.
    Zeljkovic I; Brusich S; Scherr D; Velagic V; Traykov V; Pernat A; Anic A; Szavits Nossan J; Jan M; Bakotic Z; Pezo Nikolic B; Radeljic V; Bojko A; Benko I; Manola S; Pavlovic N
    Clin Cardiol; 2021 Aug; 44(8):1177-1182. PubMed ID: 34196416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation.
    Harada M; Motoike Y; Nomura Y; Nishimura A; Koshikawa M; Murayama K; Ohno Y; Watanabe E; Izawa H; Ozaki Y
    J Arrhythm; 2020 Jun; 36(3):417-424. PubMed ID: 32528566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rivaroxaban on activated clotting time in catheter ablation for atrial fibrillation in Chinese patients.
    Songqun H; Chunling W; Zhifu G; Xinmiao H; Jiang C
    J Interv Card Electrophysiol; 2020 Dec; 59(3):509-516. PubMed ID: 31840206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
    BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.
    Yu HT; Shim J; Park J; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Kim YH; Pak HN
    Eur Heart J; 2019 May; 40(19):1531-1537. PubMed ID: 30590600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs.
    Sairaku A; Morishima N; Matsumura H; Amioka M; Maeda J; Watanabe Y; Nakano Y
    J Interv Card Electrophysiol; 2021 Sep; 61(3):551-557. PubMed ID: 32808083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
    J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
    Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
    Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K
    J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.